EMA Authorised: Levetiracetam Actavis (levetiracetam) — Actavis Group PTC ehf

View source ↗

Summary

The European Medicines Agency has authorised Levetiracetam Actavis, a generic levetiracetam product, for use in epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Levetiracetam Actavis (levetiracetam)

Snippet

Status: Authorised. Therapeutic area: Epilepsy. MAH: Actavis Group PTC ehf. Decision date: 22/01/2026